| pubmed-article:15308326 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15308326 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:15308326 | lifeskim:mentions | umls-concept:C0026473 | lld:lifeskim |
| pubmed-article:15308326 | lifeskim:mentions | umls-concept:C0108747 | lld:lifeskim |
| pubmed-article:15308326 | lifeskim:mentions | umls-concept:C1367477 | lld:lifeskim |
| pubmed-article:15308326 | lifeskim:mentions | umls-concept:C1414555 | lld:lifeskim |
| pubmed-article:15308326 | lifeskim:mentions | umls-concept:C1516031 | lld:lifeskim |
| pubmed-article:15308326 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:15308326 | pubmed:dateCreated | 2004-8-13 | lld:pubmed |
| pubmed-article:15308326 | pubmed:abstractText | Two main subpopulations of human blood monocytes are distinguished on the basis of CD14 and CD16 expression: the major population with enhanced expression of CD14 (CD14++ monocytes) and the minor one with a weak expression of CD14 coexpressing CD16 (CD14+/CD16+ monocytes). As monocytes and macrophages are involved in antitumor response of the host, we assessed the ability of CD14+/CD16+ monocytes to produce cytokines (intracellular expression, release) and reactive oxygen and nitrogen (ROI, RNI) intermediates following stimulation in vitro with tumor cells. | lld:pubmed |
| pubmed-article:15308326 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15308326 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15308326 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15308326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15308326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15308326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15308326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15308326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15308326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15308326 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15308326 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:15308326 | pubmed:issn | 0301-472X | lld:pubmed |
| pubmed-article:15308326 | pubmed:author | pubmed-author:ZembalaMarekM | lld:pubmed |
| pubmed-article:15308326 | pubmed:author | pubmed-author:SiedlarMaciej... | lld:pubmed |
| pubmed-article:15308326 | pubmed:author | pubmed-author:Baj-Krzyworze... | lld:pubmed |
| pubmed-article:15308326 | pubmed:author | pubmed-author:RuggieroIrena... | lld:pubmed |
| pubmed-article:15308326 | pubmed:author | pubmed-author:HajtoBarbaraB | lld:pubmed |
| pubmed-article:15308326 | pubmed:author | pubmed-author:WeglarczykKaz... | lld:pubmed |
| pubmed-article:15308326 | pubmed:author | pubmed-author:SzaflarskaAnn... | lld:pubmed |
| pubmed-article:15308326 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15308326 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:15308326 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15308326 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15308326 | pubmed:pagination | 748-55 | lld:pubmed |
| pubmed-article:15308326 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15308326 | pubmed:meshHeading | pubmed-meshheading:15308326... | lld:pubmed |
| pubmed-article:15308326 | pubmed:meshHeading | pubmed-meshheading:15308326... | lld:pubmed |
| pubmed-article:15308326 | pubmed:meshHeading | pubmed-meshheading:15308326... | lld:pubmed |
| pubmed-article:15308326 | pubmed:meshHeading | pubmed-meshheading:15308326... | lld:pubmed |
| pubmed-article:15308326 | pubmed:meshHeading | pubmed-meshheading:15308326... | lld:pubmed |
| pubmed-article:15308326 | pubmed:meshHeading | pubmed-meshheading:15308326... | lld:pubmed |
| pubmed-article:15308326 | pubmed:meshHeading | pubmed-meshheading:15308326... | lld:pubmed |
| pubmed-article:15308326 | pubmed:meshHeading | pubmed-meshheading:15308326... | lld:pubmed |
| pubmed-article:15308326 | pubmed:meshHeading | pubmed-meshheading:15308326... | lld:pubmed |
| pubmed-article:15308326 | pubmed:meshHeading | pubmed-meshheading:15308326... | lld:pubmed |
| pubmed-article:15308326 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15308326 | pubmed:articleTitle | Antitumor response of CD14+/CD16+ monocyte subpopulation. | lld:pubmed |
| pubmed-article:15308326 | pubmed:affiliation | Department of Clinical Immunology, Polish-American Institute of Pediatrics, Jagiellonian University Medical College, Cracow, Poland. | lld:pubmed |
| pubmed-article:15308326 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15308326 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15308326 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15308326 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15308326 | lld:pubmed |
